Showing results (571-580 of 724) with videos related to

Sort By:
Pageof 73
Arthritis Research & Therapy|December 5, 2013
PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritisJacky Woo, Michel P M Vierboom, Hakju Kwon, et al.
Annals of Biomedical Engineering|October 27, 2006
The Groningen hypothermic liver perfusion pump: functional evaluation of a new machine perfusion systemA van der Plaats, M H J Maathuis, N A 'T Hart, et al.
Diabetes Care|September 24, 2016
A Common Gene Variant in Glucokinase Regulatory Protein Interacts With Glucose Metabolism on Diabetic Dyslipidemia: the Combined CODAM and Hoorn StudiesNynke Simons, Jacqueline M Dekker, Marleen M J van Greevenbroek, et al.
BMJ Open Diabetes Research & Care|October 14, 2021
Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetesElham Memarian, Leen M 't Hart, Roderick C Slieker, et al.
Diabetes/Metabolism Research and Reviews|July 9, 2023
IgG N-glycans are associated with prevalent and incident complications of type 2 diabetesElham Memarian, Ralph Heijmans, Roderick C Slieker, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2023
Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing AutophagyYann Salemkour, Dilemin Yildiz, Léa Dionet, et al.
Journal of Neuropathology and Experimental Neurology|December 20, 2015
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter LesionsMarvin M van Luijn, Marjan van Meurs, Marcel P Stoop, et al.
BMJ Open Diabetes Research & Care|July 4, 2020
Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetesSunny S Singh, Annemieke Naber, Viktoria Dotz, et al.
Pageof 73